BSX insider trading: BOSTON SCIENTIFIC CORP insider buys & sells · Whale Atlas

BSX

NYSE

BOSTON SCIENTIFIC CORP

Latest disclosureSeptember 3, 2026

Insider score Why 60?: 60/ 100
Qualifying buys · 30d: $0

10 purchases · 0 sales

Price by TradingView

Insider transactions 41

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Showing the first 6 of 20 trades on this page.

Exercise or conversion

Padraig Andrew O.'Connor

EVP, Global Operations

Common Stock

Value context: Not established
Reported price: $0 reported · see filing

Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Tax or exercise withholding

Padraig Andrew O.'Connor

EVP, Global Operations

Common Stock

Value context: $27.43K
Reported price: $48.37 / share

Why this buying score?

Qualifying common-equity purchase value

$5,375,903 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

5 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+19 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+8 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+8 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000885725
Latest public acceptance: Sep 3, 2026, 08:34 PM UTC
Score calculated: Oct 7, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Purchase disclosed

David C. Habiger

Director

Common Stock

Reported value: $99.94K
Reported price: $47.589 / share

Purchase disclosed

David C. Habiger

Director

Common Stock

Reported value: $50.08K
Reported price: $48.0655 / share

Purchase disclosed

David C. Habiger

Director

Common Stock

Reported value: $6.8K
Reported price: $48.5879 / share

Purchase disclosed

Michael F. Mahoney

Chairman, President & CEO

Common Stock

Reported value: $9M
Reported price: $48.3323 / share

Other activity disclosed

Michael F. Mahoney

Chairman, President & CEO

Common Stock

Value context: $1.07M
Reported price: $48.43 / share

Purchase disclosed

Edward J. Ludwig

Director

Common Stock

Reported value: $227.4K
Reported price: $45.4799 / share

Other activity disclosed

Joseph Michael Fitzgerald

EVP & Group Pres, Cardiology

Common Stock

Value context: $3M
Reported price: $46.73 / share

Exercise or conversion

Jonathan Monson

EVP and CFO

Common Stock

Value context: Not established
Reported price: $0 reported · see filing

Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Tax or exercise withholding

Jonathan Monson

EVP and CFO

Common Stock

Value context: $43.49K
Reported price: $43.06 / share

Exercise or conversion

Jonathan Monson

EVP and CFO

Restricted Stock Units

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: Exercise / conversion price not reported

Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Gift disclosed

Michael F. Mahoney

Chairman, President & CEO

Common Stock

Value context: Not a purchase
Reported price: Gift · no purchase price

Understand this price

The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.

Purchase disclosed

Cheryl Pegus

Director

Common Stock

Reported value: $99.99K
Reported price: $56.49 / share

Purchase disclosed

Edward J. Ludwig

Director

Common Stock

Reported value: $202.91K
Reported price: $56.68 / share

Purchase disclosed

David C. Habiger

Director

Common Stock

Reported value: $125.28K
Reported price: $56.9451 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
EVP, Global Operations	Common StockOption exercise or conversion	1,171$0 reported · see filing	Not established	Sep 2Filed Sep 3 · 1d later	SEC filing
EVP, Global Operations	Common StockExercise-price or tax withholding	567$48.37 / share	$27.43K	Sep 2Filed Sep 3 · 1d later	SEC filing
EVP, Global Operations	Restricted Stock UnitsOption exercise or conversion	Derivative units1,171Exercise / conversion price not reported	Not a separate purchase	Sep 2Filed Sep 3 · 1d later	SEC filing
Director	Common StockPurchase	2,040$49.22 / share	$100.41K	Aug 25Filed Aug 26 · 1d later	SEC filing
SVP, Global Controller and CAO	Common StockDiscretionary transaction	2,930$51.19 / share	$149.99K	Aug 11Filed Aug 12 · 1d later	SEC filing
EVP and CFO	Common StockDiscretionary transaction	9,908$50.46 / share	$499.96K	Aug 10Filed Aug 11 · 1d later	SEC filing
Director	Common StockPurchase	2,100$47.59 / share	$99.94K	Aug 5Filed Aug 7 · 2d later	SEC filing
Director	Common StockPurchase	1,042$48.07 / share	$50.08K	Aug 3Filed Aug 5 · 2d later	SEC filing
Director	Common StockPurchase	140$48.59 / share	$6.8K	Aug 4Filed Aug 5 · 1d later	SEC filing
Chairman, President & CEO	Common StockPurchase	186,240$48.33 / share	$9M	Aug 3Filed Aug 5 · 2d later	SEC filing
Chairman, President & CEO	Common StockDiscretionary transaction	22,119$48.43 / share	$1.07M	Aug 3Filed Aug 5 · 2d later	SEC filing
Director	Common StockPurchase	5,000$45.48 / share	$227.4K	Jul 31Filed Aug 3 · 3d later	SEC filing
EVP & Group Pres, Cardiology	Common StockDiscretionary transaction	64,198$46.73 / share	$3M	Jul 31Filed Aug 3 · 3d later	SEC filing
EVP and CFO	Common StockOption exercise or conversion	2,087$0 reported · see filing	Not established	Jul 1Filed Jul 2 · 1d later	SEC filing
EVP and CFO	Common StockExercise-price or tax withholding	1,010$43.06 / share	$43.49K	Jul 1Filed Jul 2 · 1d later	SEC filing
EVP and CFO	Restricted Stock UnitsOption exercise or conversion	Derivative units2,087Exercise / conversion price not reported	Not a separate purchase	Jul 1Filed Jul 2 · 1d later	SEC filing
Chairman, President & CEO	Common StockGift	386,755Gift · no purchase price	Not a purchase	May 28Filed Jun 1 · 4d later	SEC filing
Director	Common StockPurchase	1,770$56.49 / share	$99.99K	May 20Filed May 21 · 1d later	SEC filing
Director	Common StockPurchase	3,580$56.68 / share	$202.91K	May 20Filed May 21 · 1d later	SEC filing
Director	Common StockPurchase	2,200$56.95 / share	$125.28K	May 19Filed May 21 · 2d later	SEC filing

Congress transactions 26

All Congress filings

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a joint account.

Kevin HernReporting House member

Reported amount: $50,001 – $100,000Reported range; exact amount not disclosed.
Trade date: September 9, 2026

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for a joint account.

Kevin HernReporting House member

Reported amount: $50,001 – $100,000Reported range; exact amount not disclosed.
Trade date: September 4, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a dependent.

Kevin HernReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 3, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a dependent.

Kevin HernReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 3, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a dependent.

Kevin HernReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 3, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a joint account.

Kevin HernReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: August 31, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 18, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Partial sale disclosed

Boston Scientific Corporation Common Stock · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 4, 2026

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 5, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 5, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 29, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 19, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 11, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 10, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 30, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock · Stock

The filing reports a purchase for a joint account.

Markwayne MullinReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: December 29, 2025

Partial sale disclosed

Boston Scientific Corp · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 17, 2025

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 24, 2025

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 18, 2025

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 31, 2025

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 30, 2025

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 30, 2025

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 17, 2025

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for a joint account.

Kevin HernReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: October 28, 2025

Showing the latest 25 of 26 disclosed trades. Show all 26 trades

BSX

10 purchases · 0 sales

Insider transactions 41

Padraig Andrew O.'Connor

Padraig Andrew O.'Connor

Why this buying score?

Qualifying common-equity purchase value

Distinct buying groups

CEO purchase

Material reported holdings increase

Sources and coverage

Padraig Andrew O.'Connor

Susan E. Morano

Emily Woodworth

Jonathan Monson

David C. Habiger

David C. Habiger

David C. Habiger

Michael F. Mahoney

Michael F. Mahoney

Edward J. Ludwig

Joseph Michael Fitzgerald

Jonathan Monson

Jonathan Monson

Jonathan Monson

Michael F. Mahoney

Cheryl Pegus

Edward J. Ludwig

David C. Habiger

Congress transactions 26